600 patients66,869 observations120 daysLIVE

Patient P-01360

Synthetic patientNBL-101 · Day 93 · 25–34 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Stable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
78%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 47 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 59 GI-04 recommendedGI Support Protocol GI-04
  4. Day 60 Patient acceptedStarted GI-04 in the companion
  5. Day 68 GI symptom burden −28% vs expectedGI Support Protocol GI-04
  6. Day 74 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 47.

Primary contributors, last 14 days
  • Treatment adherence-9
  • GI instability+6
  • Toxicity+4
  • Inflammatory activity+3
  • Nutritional resilience-2

What helped?

  • GI Support Protocol GI-04Day 59
    Result: symptom burden −28%
LIFE OS recommendation
Dietary Support Protocol NP-02
62%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 66% showed improvement
  • median effect visible after 10 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
59.1/100
worsening · +5.5 vs previous 14 d
Toxicity
Blood
47.8/100
worsening · +4.1 vs previous 14 d
Sleep quality
Wearable
33/100
worsening · -4.3 vs previous 14 d
Energy level
Daily log
3/10
worsening · -0.7 vs previous 14 d
Stress level
Daily log
6.7/10
worsening · +0.3 vs previous 14 d
Steps
Wearable
6,545
stable · +54 vs previous 14 d
Adherence
Companion
47.3 %
worsening · -18.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 31 from the failing basin, 61 from restoration.

Would help
  • ME-01 Monitoring Escalation
    100% improved among 77 similar · onset 3 d · confidence 76%
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 76%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 76%
Would not help
  • Keep fat low
    GI +6.4 next day on high-intake days · n 25
  • Keep fibre low
    GI +4.9 next day on high-intake days · n 23
  • Keep simple carbs low
    GI +3.1 next day on high-intake days · n 21
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +6.4detractor · 95%
  • Insoluble fibre
    +4.9detractor · 95%
  • Simple carbohydrates
    +3.1detractor · 72%
  • Histamine load
    -2.8no signal · 44%
  • Alcohol
    +1.1no signal · 21%
  • Spicy / capsaicin
    +0.4no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 60
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 59 and rising
    • WearableSleep 5.9 h, below personal baseline
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 24/100
    • Daily logFibre intake low in recent food logs
  • Drug metabolism and exposure 55
    • DNADPYD *2A → slower clearance
    • BloodToxicity index 48
  • Inflammatory signalling 45
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 59
  • Autonomic recovery 45
    • WearableResting HR 73 bpm
    • WearableShort sleep window
DNA
Fictional pharmacogenomic panel
  • DPYD *2A heterozygous
    Slower drug clearance
  • CYP2D6 Normal metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 2 · butyrate capacity 24/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
48 ms
Sleep
6.1 h
Steps
6,542
Resting HR
73 bpm
Daily log: GI score 59, nutritional resilience 40, adherence 47.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0146555%S14NP-02improved56
P-0149455%S14GI-04improved42
P-0143353%S14GI-04improved48
P-0157053%S14SC-12improved46
P-0133952%S14GI-04improved54
P-0155451%S05GI-04improved47
P-0153950%S14GI-04improved43
P-0178150%S14NP-02improved45
P-0178650%S07ME-01improved46
P-0183450%S14NP-02improved44
P-0144749%S15GI-04improved44
P-0154749%S13GI-04improved50